Consumer Defensive
Live Price
Offline$145.75
+0.00% today
1Y Change
+74.31%
Window
Jun 20, 2025 → Jun 15, 2026
Coverage: 247 bars · Jun 20, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Seneca Foods Corporation (SENEB) is a Consumer Defensive stock with a market cap of $950.00M and listed on NASDAQ. The stock last traded around $145.75 and up 74.3% across the available one-year price window (Jun 20, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +8.2%, EPS growth of -31.1%, a dividend yield of 0.0%. What stands out right now is revenue +8.2%, EPS -31.1%, free cash flow +349.4% with operating margin 7.9% and ROIC 9.0%. Valuation is more restrained than many high-expectation growth names at P/E 10.5 and price/sales 0.6. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SENEB price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SENEB
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SENEB Max Drawdown
-20.32%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SENEB and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$1.5B
+5.9% YoY
FY Net Income
$126.1M
+172.9% YoY
Free Cash Flow
$111.7M
+581.4% YoY
Revenue Growth
+8.2%
EPS Growth
-31.1%
Gross Margin
12.6%
Net Margin
5.6%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.6B | 1.5B | 1.5B | 1.4B | 1.5B |
| Gross Profit | 150M | 188M | 104M | 142M | 232M |
| Operating Income | 78M | 107M | 21M | 64M | 181M |
| EBITDA | 133M | 161M | 70M | 102M | 199M |
| Net Income | 41M | 63M | 9M | 46M | 126M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 43M | 4M | 5M | 11M | 60M |
| Total Assets | 1.2B | 1.4B | 1.2B | 942M | 909M |
| Total Liabilities | 548M | 801M | 658M | 363M | 332M |
| Shareholder Equity | 633M | 583M | 555M | 579M | 578M |
| Total Debt | 375M | 651M | 492M | 178M | 169M |
| Net Debt | 332M | 646M | 487M | 167M | 110M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
183M
+507.5% YoY
Capital Expenditures
71M
-33.8% YoY
Free Cash Flow
112M
+581.4% YoY
Key ratios
Gross Margin
12.6%
Operating Margin
7.9%
Net Margin
5.6%
ROE
13.5%
Debt / Equity
0.39x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.